Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer

Author:

von Minckwitz Gunter1,Huang Chiun-Sheng1,Mano Max S.1,Loibl Sibylle1,Mamounas Eleftherios P.1,Untch Michael1,Wolmark Norman1,Rastogi Priya1,Schneeweiss Andreas1,Redondo Andres1,Fischer Hans H.1,Jacot William1,Conlin Alison K.1,Arce-Salinas Claudia1,Wapnir Irene L.1,Jackisch Christian1,DiGiovanna Michael P.1,Fasching Peter A.1,Crown John P.1,Wülfing Pia1,Shao Zhimin1,Rota Caremoli Elena1,Wu Haiyan1,Lam Lisa H.1,Tesarowski David1,Smitt Melanie1,Douthwaite Hannah1,Singel Stina M.1,Geyer Charles E.1

Affiliation:

1. From the German Breast Group, Neu-Isenburg (G.M., S.L., H.H.F., P.W.), the Center for Hematology and Oncology Bethanien, Frankfurt (S.L.), the AGO-B and HELIOS Klinikum Berlin-Buch, Berlin (M.U.), the National Center for Tumor Diseases, Heidelberg University Hospital and German Cancer Research Center, Heidelberg (A.S.), Evangelische Kliniken Gelsenkirchen, Gelsenkirchen (H.H.F.), the Arbeitsgemeinschaft Gynäkologische Onkologie – Breast and Sana Klinikum Offenbach, Offenbach (C.J.), the Department of...

Funder

Was funded by F. Hoffmann-LaRoche/Genentech

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3